Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 55.21B | 51.39B | 47.87B | 41.83B | 39.25B |
Gross Profit | 17.39B | 15.64B | 14.02B | 12.21B | 11.48B |
EBITDA | 7.69B | 6.62B | 4.92B | 3.32B | 2.83B |
Net Income | 3.63B | 3.06B | 2.06B | 995.00M | -61.00M |
Balance Sheet | |||||
Total Assets | 74.73B | 73.48B | 64.93B | 59.94B | 56.22B |
Cash, Cash Equivalents and Short-Term Investments | 16.98B | 16.58B | 14.99B | 12.75B | 11.54B |
Total Debt | 7.23B | 7.25B | 7.55B | 7.76B | 8.61B |
Total Liabilities | 29.16B | 31.09B | 28.86B | 26.25B | 24.31B |
Stockholders Equity | 42.56B | 39.34B | 33.21B | 30.78B | 29.44B |
Cash Flow | |||||
Free Cash Flow | 2.38B | 3.08B | 4.50B | 2.87B | 1.56B |
Operating Cash Flow | 3.67B | 4.46B | 5.64B | 3.78B | 3.14B |
Investing Cash Flow | -1.32B | -1.43B | -2.04B | -712.00M | -2.16B |
Financing Cash Flow | -2.22B | -1.50B | -1.69B | -1.51B | 318.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥29.40B | 7.66 | 3.33% | 7.43% | 18.47% | ||
75 Outperform | ¥28.41B | 12.10 | 4.46% | 4.40% | 18.82% | ||
71 Outperform | ¥31.71B | 14.53 | 3.37% | -12.88% | -70.22% | ||
71 Outperform | ¥22.77B | 15.57 | 2.04% | 7.26% | 28.17% | ||
71 Outperform | ¥253.62B | 13.00 | 8.49% | 3.09% | 6.31% | 12.77% | |
69 Neutral | ¥11.55B | 20.12 | 2.55% | -10.39% | -43.57% | ||
63 Neutral | ¥33.84B | 25.15 | 1.99% | 0.68% | -22.82% |